Claude Nicaise serves as Executive at Sarepta Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Claude Nicaise has executed 12 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 29, 2026 involved exercising options for 10,500 shares valued at $0.
Claude Nicaise currently holds 31,532 shares of Sarepta Therapeutics, Inc. (SRPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Claude Nicaise has been a net neutral trader of SRPT stock. They have purchased $0 and sold $0 worth of shares.
Claude Nicaise's most recent insider trade was on Jan 29, 2026, when they sold 10,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $21.23 |
| Discretionary |
| Jan 29, 2026 | SRPT | $144.0K | Option Exercise | 10,500 | $13.71 | Discretionary |
| Mar 1, 2024 | SRPT | $0 | Award | 1,846 | $N/A | Discretionary |
| Mar 6, 2023 | SRPT | $0 | Award | 1,523 | $N/A | Discretionary |
| Mar 7, 2022 | SRPT | $0 | Award | 2,953 | $N/A | Discretionary |
| Mar 3, 2021 | SRPT | $0 | Award | 2,726 | $N/A | Discretionary |
| Feb 28, 2020 | SRPT | $0 | Award | 2,075 | $N/A | Discretionary |
| Mar 4, 2019 | SRPT | $0 | Award | 1,633 | $N/A | Discretionary |
| Mar 5, 2018 | SRPT | $0 | Award | 3,418 | $N/A | Discretionary |
| Mar 10, 2017 | SRPT | $0 | Award | 1,000 | $N/A | Discretionary |
| Feb 29, 2016 | SRPT | $0 | Award | 1,000 | $N/A | Discretionary |